These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8946950)

  • 1. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
    Wilmen A; Göke B; Göke R
    FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
    López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
    J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S; Donnelly D
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
    Van Eyll B; Göke B; Wilmen A; Göke R
    Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
    Graziano MP; Hey PJ; Strader CD
    Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
    Wilmen A; Van Eyll B; Göke B; Göke R
    Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor.
    Bazarsuren A; Grauschopf U; Wozny M; Reusch D; Hoffmann E; Schaefer W; Panzner S; Rudolph R
    Biophys Chem; 2002 May; 96(2-3):305-18. PubMed ID: 12034449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
    Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
    J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge.
    López de Maturana R; Donnelly D
    FEBS Lett; 2002 Oct; 530(1-3):244-8. PubMed ID: 12387900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
    Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
    Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.
    Xiao Q; Giguere J; Parisien M; Jeng W; St-Pierre SA; Brubaker PL; Wheeler MB
    Biochemistry; 2001 Mar; 40(9):2860-9. PubMed ID: 11258897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
    Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
    FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
    Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The positive charge of the imidazole side chain of histidine7 is crucial for GLP-1 action.
    Hareter A; Hoffmann E; Bode HP; Göke B; Göke R
    Endocr J; 1997 Oct; 44(5):701-5. PubMed ID: 9466326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.
    Hjorth SA; Adelhorst K; Pedersen BB; Kirk O; Schwartz TW
    J Biol Chem; 1994 Dec; 269(48):30121-4. PubMed ID: 7527026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
    Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
    Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of glucagon-like peptide-1 receptor-binding determinants.
    Xiao Q; Jeng W; Wheeler MB
    J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.